Intco Medical (300677.SZ) 2025 Annual Profit Distribution: RMB 1.00 per 10 shares

Gelonghui, June 3 — Intco Medical (300677.SZ) announced its 2025 annual profit distribution implementation notice. The company’s 2025 profit distribution plan is as follows: based on the current total share capital of 654,753,263 shares, excluding 3,306,180 repurchased shares, a cash dividend of RMB 1.000000 per 10 shares (tax inclusive) will be distributed to all shareholders. The record date for this profit distribution is June 10, 2026, and the ex-dividend date is June 11, 2026.

Gelonghui FinanceJun 3 17:22

Over 100 insurance asset management institutions conducted intensive research visits; In May, Huichuan Technology received visits from 30 such institutions, reflecting sustained investor interest in the technology and manufacturing sectors.

① Insurance capital remains highly focused on sectors such as electronics, semiconductors, and advanced manufacturing—industries underpinned by long-term growth fundamentals—demonstrating its role as a long-term investor with sustained interest in high-quality assets tied to technological innovation and industrial upgrading. ② Insurance institutions are characterized by their long-term investment horizon, stable funding, substantial capital scale, high tradable market value, and significant growth potential, exerting a profound influence on investments in listed companies.

cls.cnJun 2 16:34

Kaiyuan Securities: The pharmaceutical industry is gradually transitioning from old to new growth drivers, with innovation leading to breakthroughs across multiple fronts.

Chemical pharmaceuticals and biologics: Differentiated pipelines continue to emerge, overseas expansion is accelerating, and collaboration models are becoming increasingly diverse, driving sustained growth in the innovative drug industry.

Zhitong FinanceMay 22 10:15

In the past week, institutional investors have surveyed over 1,330 stocks, with Anji Technology receiving the highest number of institutional surveys.

Gelonghui, May 17 | In the past week, institutional investors conducted surveys on more than 1,330 individual stocks, with Anji Technology receiving the highest number of institutional surveys. Stocks such as Yingke Medical, Ninebot-WD, and Guangliwei received ratings from over 100 institutions each. Among the stocks surveyed by a hundred institutions, Haitai Xinguang, Sunray Technology, and Huafeng Test & Control have recently reached new all-time highs in their share prices.

Gelonghui FinanceMay 17 08:20

Intco Medical (300677.SZ): Plans to use up to 18 billion yuan of idle proprietary funds for entrusted wealth management.

Intco Medical (300677.SZ) announced that the company and its subsidiaries plan to use idle proprietary funds totaling no more than 18 billion yuan for entrusted wealth management. The company intends to primarily invest in financial products with lower risk, better liquidity, and relatively stable returns.

Zhitong FinanceMay 8 21:46

INTCO Medical (300677): Continued Validation of Profitability; Multiple Measures to Build Core Competitive Advantages

Intco Medical is a leading global enterprise in the disposable gloves industry. According to iFind, by 2025, the company is projected to achieve revenue of 9.926 billion yuan, representing a year-on-year increase of 4.23%; net profit attributable to shareholders will reach 1.011 billion yuan, reflecting a year-on-year decrease of 31.03%.

GF SecuritiesMay 7 00:00